Group One Trading’s AYTU BioPharma AYTU Stock Holding History

Group One Trading’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$80	Hold	37	–	–	﹤0.01%	7418
2026 Q1	$101	Hold	37	–	–	﹤0.01%	7427
2025 Q4	$96	Hold	37	–	–	﹤0.01%	7921
2025 Q3	$70	Hold	37	–	–	﹤0.01%	8254
2025 Q2	$81	Hold	37	–	–	﹤0.01%	7792
2025 Q1	$44	Hold	37	–	–	﹤0.01%	7428
2024 Q4	$62	Hold	37	–	–	﹤0.01%	7117
2024 Q3	$87	Hold	37	–	–	﹤0.01%	6482
2024 Q2	$108	Hold	37	–	–	﹤0.01%	6551
2024 Q1	$112	Hold	37	–	–	﹤0.01%	6840
2023 Q4	$105	Hold	37	–	–	﹤0.01%	7195
2023 Q3	$100	Hold	37	–	–	﹤0.01%	7476
2023 Q2	$59	Hold	37	–	–	﹤0.01%	7537
2023 Q1	$83	Sell	37 -1,973	-98%	-$5.77K	﹤0.01%	7041
2022 Q4	$7.6K	Sell	2,010 -20	-1%	-$75	﹤0.01%	6147
2022 Q3	$8K	Hold	2,030	–	–	﹤0.01%	6600
2022 Q2	$28K	Buy	2,030 +1,605	+378%	+$20.5K	﹤0.01%	6025
2022 Q1	$9K	Buy	425 +255	+150%	+$6.34K	﹤0.01%	7189
2021 Q4	$5K	Sell	170 -930	-85%	-$40.2K	﹤0.01%	7618
2021 Q3	$63K	Buy	1,100 +82	+8%	+$6.15K	﹤0.01%	6342
2021 Q2	$102K	Buy	1,018 +755	+287%	+$88.6K	﹤0.01%	5927
2021 Q1	$40K	Buy	+263	New	+$41.7K	﹤0.01%	6371
2020 Q4	–	Hold	0	–	–	–	6478
2020 Q3	–	Hold	0	–	–	–	6066
2020 Q2	–	Hold	0	–	–	–	5780
2020 Q1	–	Hold	0	–	–	–	5241
2019 Q4	–	Hold	0	–	–	–	5110
2019 Q3	–	Hold	0	–	–	–	5130
2019 Q2	–	Hold	0	–	–	–	4937
2019 Q1	–	Hold	0	–	–	–	4790
2018 Q4	–	Hold	0	–	–	–	4711
2018 Q3	–	Hold	0	–	–	–	5173

Other funds holding AYTU

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return

Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Group One Trading's AYTU Position: Q2 2026 in Review

Group One Trading held its AYTU BioPharma (AYTU) position steady in Q2 2026 at 37 shares worth $80. The position accounts for ﹤0.01% of the portfolio, ranked #7418.

Group One Trading first reported a position in AYTU in Q1 2021 and has held it in 22 quarters since. The position peaked at $102K in Q2 2021. 38 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

Group One Trading held 37 shares of AYTU BioPharma worth $80 as of Q2 2026.
Group One Trading left its AYTU BioPharma share count unchanged in Q2 2026.
AYTU BioPharma made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7418 holding.
Group One Trading first reported a position in AYTU BioPharma in Q1 2021 and has held it in 22 quarters since.
Group One Trading's AYTU BioPharma position peaked at $102K in Q2 2021.
38 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.